AIDS Vaccine Conference 2011
Where: Bangkok, Thailand
When: September 12 - September 15, 2011
AIDS Vaccine 2011 will provide an interactive forum for the participation of leaders and future leaders in the HIV vaccine field—policymakers and funders, multidisciplinary and highly specialized researchers, promising and talented young scientists, public-health experts, clinicians, epidemiologists, representatives of community associations and community advocates, and members of the private HIV vaccine-development sector—thereby fostering and strengthening a collaborative global network and a global research environment.
The final program is now available here.
For those of you unable to attend in person, there are a number of ways to follow the conference remotely. AVAC and others will be tweeting real-time updates from Bangkok (follow AVAC @hivpxresearch and/or follow #aidsvax11 on Twitter). The conference organizers have also organized webcasts of plenary sessions and press conferences. Session webcasts will be posted the next day—check them out on the conference website or AVAC’s Facebook page.
Photos from the conference may be seen below.
Webcasts of selected sessions are available here.
For further information, visit the conference website: www.vaccineenterprise.com/conference/2011.The following are satellite sessions that may be of interest:
An AIDS-Free Africa Through an
Effective Vaccine - Prospects, Progress, and
Challenges
Monday, September 12
8:30 - 10:30
Lotus 1-2, Level 22
Open Session
Host Institutions: The African AIDS Vaccine Partnership (AAVP), The Global Vaccine Enterprise, and AVAC
Session Chairs: Dr. Alash’le Abimiku, Dr. Saladin Osmanov
The AAVP satellite meeting aims to bring together all stakeholders attending the conference to critically appraise the progress towards an AIDS vaccine that can be used in Africa. The overall goal is to identify gaps in Africa’s response to HIV vaccine R&D, with the following objectives:
1. Provide a forum for engagement of
scientists and community
activists with a view to identifying obstacles
to effective participation
of African stakeholders in HIV vaccine
R&D.
2. Disseminate AAVP’s new strategic direction
and plans to all
stakeholders, and seek input of participants on
ways of enhancing
the AAVP’s relevance to the different
stakeholders.
Gathering Sexual Risk Information in
HIV Biomedical Prevention Trials—An Offering
of Best Practices
Monday, September 12
12 - 15:30
Lotus Suite 3
Click here for more information.
Moving Forward Together: Research
Literacy and Community Engagement in 2011 and
Beyond
Monday, September 12
8:30-15:30
Lotus 7, Level 22
Open Session
Host Institutions: Thai NGO Coalition on AIDS (TNCA), AVAC, HVTN, IAVI, UNAIDS and US Military HIV Research Program-Armed Forces Research Institute of Medical Sciences
Session Chairs: Udom Likhitwonnawut, Nusara Thaitawat
This satellite will include interactive capacity-building sessions, panels and roundtable discussions that will provide advocates, researchers and community stakeholders an opportunity to identify key issues in the evolving research agenda and provide context for the conference.
UPDATE: Photos from the session
below.




